Kalorama’s Market Estimates Featured in INN article on CRISPR Technology
Investor News Network cited Kalorama Information’s market numbers in their recent article on the rise of CRISPR Gene Editing Technology
Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- IVD Trends to Watch: Breakthroughs in Histology and Cytology July 10, 2024
- Cell and Gene Therapy Investments Reach $5 Billion in Q1 2024, $35 Billion Total in 2023 July 9, 2024
- IVD Trends to Watch: The Evolution of Point-of-Care (POC) Diagnostic Testing June 14, 2024
- IVD Trends to Watch: AI and the Future of Digital Pathology May 28, 2024
- Dynamic Landscape for Cell and Gene Therapy in 2024 May 22, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group